Vialwirebiotech, curated
September 30, 2026, 9:35 AM
September 10, 2026
- 9:34 AM · Pharmaceutical Executive9:34 AM<![CDATA[Artisan Partners’ Director Calls for Novartis Board Shake-Up ]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMCDR-Life discloses T-cell engager for axial spondyloarthritis — BioWorld
- 9:00 AM · BioWorld9:00 AMAdagene earns milestone under Exelixis ADC collaboration — BioWorld
- 9:00 AM · BioWorld9:00 AMTwostep Therapeutics gains IND clearance for TS-104 — BioWorld
- 9:00 AM · BioWorld9:00 AMSchrödinger introduces Tectora Therapeutics — BioWorld
- 9:00 AM · BioWorld9:00 AMMighty Therapeutics begins IND-enabling studies of MYTX-255 — BioWorld
- 9:00 AM · BioWorld9:00 AM1cbio and Lee’s sign license deal for PARP1 inhibitor OC-3 — BioWorld
- 9:00 AM · BioWorld9:00 AMNovartis’ PET tracer targets brain NLRP3 inflammasome — BioWorld
- 9:00 AM · BioWorld9:00 AMFull-Life’s [225Ac]Ac-FL-261 cleared for clinic in US, Australia — BioWorld
- 6:30 AM · STAT News
- 6:08 AM · SCMP — Tech
- 5:00 AM · Drug Discovery World5:00 AMPositive results for anti-IL-15 monoclonal antibody in coeliac disease — Drug Discovery World
September 9, 2026
- 8:00 PM · Nature Biotechnology8:00 PMFDA approves oncolytic virus — Nature Biotechnology
- 8:00 PM · Nature Biotechnology8:00 PMModerna flu vaccine wins FDA approval — Nature Biotechnology
- 4:15 PM · Nikkei Asia4:15 PMMitsui to help speed cancer drug research in Asia with patient database — Nikkei Asia
- 12:59 PM · SCMP — Tech12:59 PMAI researcher quits Anthropic over superintelligence fears: ‘gambling with our lives’ — SCMP — Tech
- 12:34 PM · Ars Technica — Science12:34 PMGoogle's AI genome system evaluates every possible one-base change — Ars Technica — Science
- 12:01 PM · STAT News
- 12:00 PM · BioWorld12:00 PMPharvaris preps for MAA on deucrictibant data for HAE — BioWorld
- 12:00 PM · BioWorld12:00 PMEvommune’s EVO-756 fails dermatitis study; focus on migraine — BioWorld
- 12:00 PM · BioWorld12:00 PMImdelltra-Imfinzi meets OS goal in frontline maintenance ES-SCLC — BioWorld
- 12:00 PM · BioWorld12:00 PMBalversa reversa? Tyra’s bladder cancer drug hits in phase II — BioWorld
- 12:00 PM · BioWorld12:00 PMAnti-kickback law at play, court tells Vertex as it schools HHS — BioWorld
- 12:00 PM · BioWorld12:00 PMMixed data cloud Kyowa Kirin’s nAMD eye drop bid — BioWorld
- 10:41 AM · Pharmaceutical Executive
- 10:36 AM · Pharmaceutical Technology10:36 AMERS 2026: GB-0895 clinical results show potential of next-gen anti-TSLP for asthma — Pharmaceutical Technology
- 9:48 AM · PharmaVoice9:48 AMMerck pairs ADCs with Keytruda in women’s cancer push — PharmaVoice
- 9:22 AM · Pharmaceutical Executive9:22 AM<![CDATA[HHS Confirms Four Senior FDA Leaders, Including Agency's First-Ever AI Deputy Commissioner]]> — Pharmaceutical Executive
- 9:00 AM · Drug Discovery World9:00 AMUltragenyx’s ASO for Angelman Syndrome fails at Phase III — Drug Discovery World
- 9:00 AM · BioWorld9:00 AMCSPC’s SYH-2083 cleared for clinic in China for dry eye disease — BioWorld
- 9:00 AM · BioWorld9:00 AMAlebund’s AP-308 gains IND clearance for IgA nephropathy — BioWorld
- 9:00 AM · BioWorld9:00 AMNovartis details discovery of WIZ molecular glue degrader ITU-512 — BioWorld
- 9:00 AM · BioWorld9:00 AMAndarta gains rights to Teva’s FASN inhibitors for Parkinson’s — BioWorld
- 9:00 AM · BioWorld9:00 AMChina’s NMPA clears Innocare’s bispecific ADC ICP-B381 for clinic — BioWorld
- 9:00 AM · BioWorld9:00 AMNew MUC16-targeting ADC reported in Biontech patent — BioWorld
- 9:00 AM · BioWorld9:00 AMSurrozen files SZN-8141 IND application for DME — BioWorld
- 9:00 AM · BioWorld9:00 AMAllogenetics seeks to improve organ transplantation outcomes — BioWorld
- 8:34 AM · SCMP — Tech
- 7:00 AM · Drug Discovery World7:00 AMPhase II data show durable responses in head and neck cancer — Drug Discovery World
- 7:00 AM · STAT News
- 6:19 AM · Pharmaceutical Technology6:19 AM“Unparalleled opportunity”: Sandoz embarks on ambitious biosimilar growth strategy — Pharmaceutical Technology
- 5:59 AM · Pharmaceutical Technology5:59 AMGilead launches research facility in US for new medicine development — Pharmaceutical Technology
- 4:49 AM · Pharmaceutical Technology4:49 AMFDA grants RMAT designation to RiboX’s RXRG001 for xerostomia — Pharmaceutical Technology
- 4:00 AM · Drug Discovery World4:00 AMBII allocates eight million euros to three drug discovery companies — Drug Discovery World
- 4:00 AM · Labiotech (EU)4:00 AMEli Lilly’s pipeline in 2026: how the incretin boom is funding what comes next — Labiotech (EU)
- 1:01 AM · SCMP — Tech1:01 AMChina needs monkeys: lab animal shortage could hinder biotech growth — SCMP — Tech
September 8, 2026
- 2:41 PM · BioPharma Dive2:41 PMRoivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapy — BioPharma Dive
- 1:38 PM · STAT News
- 12:28 PM · Pharmaceutical Technology12:28 PMQuoin in line for second priority review voucher if rare paediatric drug approved — Pharmaceutical Technology
- 12:00 PM · BioWorld12:00 PMSky Labs shares extend rally after $15M Kosdaq IPO — BioWorld
- 12:00 PM · BioWorld12:00 PMMenarini licenses Gan & Lee's biweekly GLP-1 for Europe — BioWorld
- 12:00 PM · BioWorld12:00 PMGSK gaining rights to Hutchmed’s KRAS/EFGR drug in $1.295B deal — BioWorld
- 12:00 PM · BioWorld12:00 PMChina clears Everest heart spray, Simcere RSV antibody — BioWorld
- 12:00 PM · BioWorld12:00 PMDouble trouble for Novartis as DM1, CV phase IIIs crash — BioWorld
- 12:00 PM · BioWorld12:00 PMDamages from med-tech cyberattacks adding up — BioWorld
- 11:52 AM · BioPharma Dive11:52 AMMoonwalk reloads with $70M and new RNAi prospects for obesity — BioPharma Dive